Literature DB >> 21553140

Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs.

Mio Kitano1, Reza Rahbari, Erin E Patterson, Yin Xiong, Nijaguna B Prasad, Yongchun Wang, Martha A Zeiger, Electron Kebebew.   

Abstract

BACKGROUND: The incidence of thyroid cancer is increasing worldwide. The findings of up to 30% of thyroid fine-needle aspiration biopsies (FNAB) are inconclusive, primarily as a result of several thyroid histologic subtypes with overlapping cytologic features. MicroRNAs (miRNAs) are small noncoding RNAs and have been implicated in carcinogenesis. We hypothesized that there are miRNAs that are differentially expressed between benign and malignant thyroid tumors that are difficult to distinguish by FNAB.
METHODS: The expression of 1263 human miRNAs was profiled in 47 tumor samples representing difficult to diagnose histologic subtypes of thyroid neoplasm (21 benign, 26 malignant). Differentially expressed miRNAs were validated by quantitative real-time reverse transcriptase-polymerase chain reaction. The area under the receiver operating characteristic curve (AUC) was used to determine the diagnostic accuracy of differentially expressed miRNAs.
RESULTS: Supervised hierarchical cluster analysis demonstrated grouping of 2 histologies (papillary and follicular thyroid carcinoma). A total of 34 miRNAs were differentially expressed in malignant compared to benign thyroid neoplasms (P<0.05). A total of 25 of the 34 nonproprietary miRNAs were selected for validation, and 15 of the 25 miRNAs were differentially expressed between benign and malignant samples with P-value<0.05. Seven miRNAs had AUC values of >0.7. miR-7 and miR-126 had the highest diagnostic accuracy with AUCs values of 0.81 and 0.77, respectively.
CONCLUSION: To our knowledge, this is the first study to evaluate the diagnostic accuracy of miRNAs in thyroid histologies that are difficult to distinguish as benign or malignant by FNAB. miR-126 and miR-7 had high diagnostic accuracy and could be helpful adjuncts to thyroid FNAB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553140      PMCID: PMC3474204          DOI: 10.1245/s10434-011-1766-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  67 in total

1.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.

Authors:  H Gharib; E Papini; R Paschke; D S Duick; R Valcavi; L Hegedüs; P Vitti
Journal:  J Endocrinol Invest       Date:  2010       Impact factor: 4.256

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.

Authors:  Constantine G A Theoharis; Kevin M Schofield; Lynwood Hammers; Robert Udelsman; David C Chhieng
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 4.  let-7 and miR-17-92: small-sized major players in lung cancer development.

Authors:  Hirotaka Osada; Takashi Takahashi
Journal:  Cancer Sci       Date:  2011-01       Impact factor: 6.716

Review 5.  MicroRNAs, cancer and cancer stem cells.

Authors:  Amy L Zimmerman; Shiyong Wu
Journal:  Cancer Lett       Date:  2010-10-20       Impact factor: 8.679

Review 6.  Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls.

Authors:  M Regina Castro; Hossein Gharib
Journal:  Endocr Pract       Date:  2003 Mar-Apr       Impact factor: 3.443

7.  MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

Authors:  Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Suresh K Rayala; Rakesh Kumar
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

8.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Authors:  R Visone; P Pallante; A Vecchione; R Cirombella; M Ferracin; A Ferraro; S Volinia; S Coluzzi; V Leone; E Borbone; C-G Liu; F Petrocca; G Troncone; G A Calin; A Scarpa; C Colato; G Tallini; M Santoro; C M Croce; A Fusco
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

Review 9.  Recent developments in predicting thyroid malignancy.

Authors:  Michael T Stang; Sally E Carty
Journal:  Curr Opin Oncol       Date:  2009-01       Impact factor: 3.645

10.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Authors:  Yoshimasa Saito; Jeffrey M Friedman; Yoshitomo Chihara; Gerda Egger; Jody C Chuang; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-29       Impact factor: 3.322

View more
  23 in total

1.  Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.

Authors:  Mio Kitano; Reza Rahbari; Erin E Patterson; Seth M Steinberg; Nijaguna B Prasad; Yongchun Wang; Martha A Zeiger; Electron Kebebew
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.568

2.  MicroRNA expression profiles in differentiated thyroid cancer, a review.

Authors:  Xinying Li; Asim B Abdel-Mageed; Debasis Mondal; Emad Kandil
Journal:  Int J Clin Exp Med       Date:  2012-11-18

Review 3.  MicroRNAs in the thyroid.

Authors:  Myriem Boufraqech; Joanna Klubo-Gwiezdzinska; Electron Kebebew
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-11-01       Impact factor: 4.690

4.  Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.

Authors:  Yang Zhang; Qi Zhong; Xiaohong Chen; Jugao Fang; Zhigang Huang
Journal:  Tumour Biol       Date:  2014-06-19

Review 5.  MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.

Authors:  Haggi Mazeh
Journal:  Oncologist       Date:  2012-06-15

Review 6.  The significance of hurthle cells in thyroid disease.

Authors:  Jennifer Cannon
Journal:  Oncologist       Date:  2011-09-30

Review 7.  MicroRNA expression profiles in the management of papillary thyroid cancer.

Authors:  James C Lee; Justin S Gundara; Anthony Glover; Jonathan Serpell; Stan B Sidhu
Journal:  Oncologist       Date:  2014-10-16

8.  Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.

Authors:  Juanjuan Zhao; Kailing Wang; Zhenyuan Liao; Ying Li; Hang Yang; Chao Chen; Y A Zhou; Yijin Tao; Mengmeng Guo; Tao Ren; Lin Xu
Journal:  Mol Clin Oncol       Date:  2015-09-16

9.  Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.

Authors:  Yi-Li Zhou; Chao Liu; Xuan-xuan Dai; Xiao-Hua Zhang; Ou-Chen Wang
Journal:  Med Oncol       Date:  2012-08-02       Impact factor: 3.064

Review 10.  MicroRNAs: molecular features and role in cancer.

Authors:  Elodie Lages; Helene Ipas; Audrey Guttin; Houssam Nesr; Francois Berger; Jean-Paul Issartel
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.